Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Diagnostik und Therapie einer IgE-vermittelten Insulinallergie: zwei Fallberichte.

Belge KI, Fischer J, Glatthaar G, Pietschke K, Yazdi AS.

J Dtsch Dermatol Ges. 2019 May;17(5):543-545. doi: 10.1111/ddg.13832_g. No abstract available.

PMID:
31115980
2.

ST18 Enhances PV-IgG-Induced Loss of Keratinocyte Cohesion in Parallel to Increased ERK Activation.

Radeva MY, Walter E, Stach RA, Yazdi AS, Schlegel N, Sarig O, Sprecher E, Waschke J.

Front Immunol. 2019 Apr 17;10:770. doi: 10.3389/fimmu.2019.00770. eCollection 2019.

3.

Diagnosis and treatment of IgE-mediated insulin hypersensitivity: two case reports.

Belge KI, Fischer J, Glatthaar G, Pietschke K, Yazdi AS.

J Dtsch Dermatol Ges. 2019 May;17(5):543-545. doi: 10.1111/ddg.13832. Epub 2019 Apr 17. No abstract available.

PMID:
30994245
4.

[Hydrochlorothiazide and nonmelanoma skin cancer].

Geyer S, Yazdi AS.

Hautarzt. 2019 Feb;70(2):148-149. doi: 10.1007/s00105-019-4354-3. German. No abstract available.

PMID:
30659335
5.

NLRP1 Is the Key Inflammasome in Primary Human Keratinocytes.

Burian M, Yazdi AS.

J Invest Dermatol. 2018 Dec;138(12):2507-2510. doi: 10.1016/j.jid.2018.08.004.

PMID:
30466537
6.

Mehrere livid-erythematöse Maculae und Plaques mit leichter Abschuppung bei einem jungen Mann.

Müller A, Wolfsperger F, Kofler L, Yazdi AS.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1282-1285. doi: 10.1111/ddg.13655_g. No abstract available.

PMID:
30300487
7.

Multiple livid-erythematous macules and plaques with slight scaling in a young man.

Müller A, Wolfsperger F, Kofler L, Yazdi AS.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1282-1285. doi: 10.1111/ddg.13655. Epub 2018 Sep 24. No abstract available.

PMID:
30248227
8.

[No increased risk of severe infections under biologic therapies in psoriasis].

Sossau D, Yazdi AS.

Hautarzt. 2018 Jul;69(7):609-610. doi: 10.1007/s00105-018-4209-3. German. No abstract available.

PMID:
29808270
9.

Prevalence of type I sensitization to alpha-gal in forest service employees and hunters: Is the blood type an overlooked risk factor in epidemiological studies of the α-Gal syndrome?

Cabezas-Cruz A, de la Fuente J, Fischer J, Hebsaker J, Lupberger E, Blumenstock G, Aichinger E, Yazdi AS, Enkel S, Oehme R, Biedermann T.

Allergy. 2017 Dec;72(12):2044-2047. doi: 10.1111/all.13206. No abstract available.

PMID:
29159820
10.

[Computer-based diagnosis of skin cancer using artificial intelligence].

Wolfsperger FC, Yazdi AS.

Hautarzt. 2017 Oct;68(10):859-861. doi: 10.1007/s00105-017-4040-2. German. No abstract available.

PMID:
28864890
11.

Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition.

Mamantopoulos M, Ronchi F, Van Hauwermeiren F, Vieira-Silva S, Yilmaz B, Martens L, Saeys Y, Drexler SK, Yazdi AS, Raes J, Lamkanfi M, McCoy KD, Wullaert A.

Immunity. 2017 Aug 15;47(2):339-348.e4. doi: 10.1016/j.immuni.2017.07.011. Epub 2017 Aug 8.

12.

Induction of skin-pathogenic Th22 cells by epicutaneous allergen exposure.

Glocova I, Brück J, Geisel J, Müller-Hermelink E, Widmaier K, Yazdi AS, Röcken M, Ghoreschi K.

J Dermatol Sci. 2017 Sep;87(3):268-277. doi: 10.1016/j.jdermsci.2017.06.006. Epub 2017 Jun 9.

PMID:
28655472
13.

Differential induction of ATF3 and HO-1 in myeloid cells and keratinocytes via Dimethylfumarate or Cyclosporine A.

Müller S, Smatlik N, Burian M, Ghoreschi K, Röcken M, Yazdi AS.

J Dermatol Sci. 2017 Sep;87(3):246-251. doi: 10.1016/j.jdermsci.2017.06.005. Epub 2017 Jun 12.

PMID:
28633807
14.

Generalized palisaded neutrophilic and granulomatous dermatitis-a cutaneous manifestation of chronic myelomonocytic leukemia? A clinical, histopathological, and molecular study of 3 cases.

Federmann B, Bonzheim I, Yazdi AS, Schmidt J, Fend F, Metzler G.

Hum Pathol. 2017 Jun;64:198-206. doi: 10.1016/j.humpath.2017.04.010. Epub 2017 Apr 22.

PMID:
28442268
15.

[Benefits of zoster vaccination in older patients].

Meier K, Yazdi AS.

Hautarzt. 2017 May;68(5):418-420. doi: 10.1007/s00105-017-3974-8. German. No abstract available.

PMID:
28342155
16.

Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation.

Brück J, Holstein J, Glocova I, Seidel U, Geisel J, Kanno T, Kumagai J, Mato N, Sudowe S, Widmaier K, Sinnberg T, Yazdi AS, Eberle FC, Hirahara K, Nakayama T, Röcken M, Ghoreschi K.

Sci Rep. 2017 Mar 14;7:44482. doi: 10.1038/srep44482.

17.

Prevalence of type I sensitization to alpha-gal in forest service employees and hunters.

Fischer J, Lupberger E, Hebsaker J, Blumenstock G, Aichinger E, Yazdi AS, Reick D, Oehme R, Biedermann T.

Allergy. 2017 Oct;72(10):1540-1547. doi: 10.1111/all.13156. Epub 2017 May 10.

PMID:
28273338
18.

Intraläsionale Therapie niedrig maligner primär kutaner B-Zell-Lymphome mit Anti-CD20-Antikörper: Nebenwirkungen korrelieren mit gutem klinischen Ansprechen.

Eberle FC, Holstein J, Scheu A, Fend F, Yazdi AS.

J Dtsch Dermatol Ges. 2017 Mar;15(3):319-324. doi: 10.1111/ddg.13188_g.

PMID:
28252849
19.

Intralesional anti-CD20 antibody for low-grade primary cutaneous B-cell lymphoma: Adverse reactions correlate with favorable clinical outcome.

Eberle FC, Holstein J, Scheu A, Fend F, Yazdi AS.

J Dtsch Dermatol Ges. 2017 Mar;15(3):319-323. doi: 10.1111/ddg.13188. Epub 2017 Feb 8.

PMID:
28177583
20.

H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.

Maurer M, Staubach P, Raap U, Richter-Huhn G, Bauer A, Ruëff F, Jakob T, Yazdi AS, Mahler V, Wagner N, Lippert U, Hillen U, Schwinn A, Pawlak M, Behnke N, Chaouche K, Chapman-Rothe N.

Clin Exp Allergy. 2017 May;47(5):684-692. doi: 10.1111/cea.12900. Epub 2017 Mar 2.

PMID:
28160338
21.

ADF Winter School-An exciting concept of the Arbeitsgemeinschaft Dermatologische Forschung to connect young scientists and clinician scientists in Dermatology at the top of Germany.

Yazdi AS, Barlin M, Böhm K, Gendrisch F, Ghorbanalipoor S, Häberle S, Hamel A, Hüning S, Hüttner C, Iwanova I, Kanaki T, Kimeswenger S, Lohmann N, Munir S, Muzumdar S, Pereira MP, Peking P, Plesser K, Rendon A, Rentschler M, Schlumprecht C, Smorodchenko A, Stock M, Tillmanns J, Uslu U, Ghoreschi K, Glatz M, Grabbe S, Kunz M, Ludwig R, Scharffetter-Kochanek K, Loser K.

Exp Dermatol. 2017 Mar;26(3):292-294. doi: 10.1111/exd.13241. Epub 2016 Nov 3. No abstract available.

PMID:
27808431
22.

Silencing of ASC in Cutaneous Squamous Cell Carcinoma.

Meier K, Drexler SK, Eberle FC, Lefort K, Yazdi AS.

PLoS One. 2016 Oct 21;11(10):e0164742. doi: 10.1371/journal.pone.0164742. eCollection 2016.

23.

The Interleukin-1 Family.

Yazdi AS, Ghoreschi K.

Adv Exp Med Biol. 2016;941:21-29. Review.

PMID:
27734407
24.

[Lymph node dissection in sentinel lymph node-positive malignant melanoma].

Welsch K, Yazdi AS.

Hautarzt. 2016 Oct;67(10):848-849. German. No abstract available.

PMID:
27573344
25.

Clinical spectrum of α-Gal syndrome: from immediate-type to delayed immediate-type reactions to mammalian innards and meat.

Fischer J, Yazdi AS, Biedermann T.

Allergo J Int. 2016;25:55-62. Epub 2016 Mar 23. Review.

26.

MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.

Schmitt A, Grondona P, Maier T, Brändle M, Schönfeld C, Jäger G, Kosnopfel C, Eberle FC, Schittek B, Schulze-Osthoff K, Yazdi AS, Hailfinger S.

J Invest Dermatol. 2016 Apr;136(4):788-797. doi: 10.1016/j.jid.2015.12.027. Epub 2016 Jan 6.

27.

Cutaneous immunology: basics and new concepts.

Yazdi AS, Röcken M, Ghoreschi K.

Semin Immunopathol. 2016 Jan;38(1):3-10. doi: 10.1007/s00281-015-0545-x. Epub 2015 Nov 12. Review.

PMID:
26563284
28.

[Modern allergy diagnostic procedures and their clinical application].

Fischer J, Yazdi AS.

Hautarzt. 2016 Jan;67(1):27-32. doi: 10.1007/s00105-015-3722-x. Review. German.

PMID:
26530489
29.

The two faces of the inflammasome adaptor ASC in epithelial skin carcinogenesis.

Yazdi AS, Drexler SK.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S94-6. Epub 2015 Oct 12. Review.

PMID:
26457824
30.

Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.

Brück J, Pascolo S, Fuchs K, Kellerer C, Glocova I, Geisel J, Dengler K, Yazdi AS, Röcken M, Ghoreschi K.

J Immunol. 2015 Sep 1;195(5):2216-23. doi: 10.4049/jimmunol.1402989. Epub 2015 Jul 31.

31.

Panitumumab: A safe option for oncologic patients sensitized to galactose-α-1,3-galactose.

Caponetto P, Biedermann T, Yazdi AS, Fischer J.

J Allergy Clin Immunol Pract. 2015 Nov-Dec;3(6):982-3. doi: 10.1016/j.jaip.2015.06.015. Epub 2015 Jul 17. No abstract available.

PMID:
26194457
32.

Restless legs syndrome in psoriasis: an unexpected comorbidity.

Schell C, Schleich R, Walker F, Yazdi AS, Lerche H, Röcken M, Axmann D, Ghoreschi K, Eberle FC.

Eur J Dermatol. 2015 May-Jun;25(3):255-60. doi: 10.1684/ejd.2015.2525.

PMID:
25786537
33.

Quantitative proteomics of the human skin secretome reveal a reduction in immune defense mediators in ectodermal dysplasia patients.

Burian M, Velic A, Matic K, Günther S, Kraft B, Gonser L, Forchhammer S, Tiffert Y, Naumer C, Krohn M, Berneburg M, Yazdi AS, Maček B, Schittek B.

J Invest Dermatol. 2015 Mar;135(3):759-767. doi: 10.1038/jid.2014.462. Epub 2014 Oct 27.

34.

[Sentinel lymph node biopsy and its diagnostic and therapeutic importance].

Kofler L, Yazdi AS.

Hautarzt. 2014 Nov;65(11):981-2. doi: 10.1007/s00105-014-3522-8. German. No abstract available.

PMID:
25260304
35.

[Effective oral immunotherapy for peanut allergy].

Yazdi AS.

Hautarzt. 2014 Apr;65(4):351-2. doi: 10.1007/s00105-014-2788-1. German. No abstract available.

PMID:
24663392
36.
37.

Complex roles of inflammasomes in carcinogenesis.

Drexler SK, Yazdi AS.

Cancer J. 2013 Nov-Dec;19(6):468-72. doi: 10.1097/PPO.0000000000000004. Review.

PMID:
24270345
38.

[Allergen-specific immunotherapy for atopic dermatitis].

Yazdi AS.

Hautarzt. 2013 Dec;64(12):949-51. doi: 10.1007/s00105-013-2689-8. Review. German. No abstract available.

PMID:
24141430
39.

Cutaneous presentation of hematological malignancies.

Eberle FC, Metzler G, Weisel KC, Berneburg M, Yazdi AS.

Eur J Dermatol. 2013 May-Jun;23(3):372-7. doi: 10.1684/ejd.2013.2010.

PMID:
23782893
40.

[Validity of the current classification of cutaneous squamous cell carcinoma].

Meier K, Yazdi AS.

Hautarzt. 2013 May;64(5):384-6. doi: 10.1007/s00105-013-2564-7. German. No abstract available.

PMID:
23595892
41.

Regulation of interleukin 1α secretion by inflammasomes.

Yazdi AS, Drexler SK.

Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii96-9. doi: 10.1136/annrheumdis-2012-202252. Epub 2012 Dec 19. Review.

PMID:
23253918
42.

[Skin bacteria direct the immune response].

Yazdi AS.

Hautarzt. 2012 Dec;63(12):985-7. doi: 10.1007/s00105-012-2490-0. Review. German. No abstract available.

PMID:
23160452
43.

Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis.

Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H, Schneider P, Gross O, Tschopp J, Yazdi AS.

Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18384-9. doi: 10.1073/pnas.1209171109. Epub 2012 Oct 22.

44.

[Genetic variations of a tumor].

Yazdi AS.

Hautarzt. 2012 Jul;63(7):587-8. doi: 10.1007/s00105-012-2412-1. German. No abstract available.

PMID:
22733243
45.

[Genetic risk of atopic dermatitis. Epidermal barrier and immunological dysregulation].

Yazdi AS.

Hautarzt. 2012 Feb;63(2):161-2. German. No abstract available.

PMID:
22457879
46.

Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.

Gross O, Yazdi AS, Thomas CJ, Masin M, Heinz LX, Guarda G, Quadroni M, Drexler SK, Tschopp J.

Immunity. 2012 Mar 23;36(3):388-400. doi: 10.1016/j.immuni.2012.01.018.

47.

[Genetic risk of atopic dermatitis : Epidermal barrier and immunological dysregulation.]

Yazdi AS.

Hautarzt. 2012 Feb 1. [Epub ahead of print] German. No abstract available.

PMID:
22290280
48.

Differential expression of NLRP3 among hematopoietic cells.

Guarda G, Zenger M, Yazdi AS, Schroder K, Ferrero I, Menu P, Tardivel A, Mattmann C, Tschopp J.

J Immunol. 2011 Feb 15;186(4):2529-34. doi: 10.4049/jimmunol.1002720. Epub 2011 Jan 21.

49.

A role for mitochondria in NLRP3 inflammasome activation.

Zhou R, Yazdi AS, Menu P, Tschopp J.

Nature. 2011 Jan 13;469(7329):221-5. doi: 10.1038/nature09663. Epub 2010 Dec 1. Erratum in: Nature. 2011 Jul 7;475(7354):122.

PMID:
21124315
50.

Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β.

Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19449-54. doi: 10.1073/pnas.1008155107. Epub 2010 Oct 25.

Supplemental Content

Loading ...
Support Center